TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer.

G Deplanque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.